吡非尼酮
任天堂
特发性肺纤维化
医学
重症监护医学
成本效益
肺纤维化
内科学
纤维化
肺
风险分析(工程)
作者
Aziz Rezapour,Mohammad Veysi-Sheykhrobat,Aghdas Souresrafil,Sajad Moeini,Tayebe Roghani,Abdollah Sayyad,Ahmad Tahmasebi-Ghorrabi
标识
DOI:10.1080/14737167.2025.2480718
摘要
Introduction Objective: To systematically review studies on the cost-effectiveness of pirfenidone compared to nintedanib in patients with idiopathic pulmonary fibrosis (IPF).
科研通智能强力驱动
Strongly Powered by AbleSci AI